Literature DB >> 10928566

Prevalence of multi-drug resistant Salmonella typhi among clinically diagnosed typhoid fever patients in Lagos, Nigeria.

K O Akinyemi1, A O Coker, D K Olukoya, A O Oyefolu, E P Amorighoye, E O Omonigbehin.   

Abstract

A total of 635 clinically diagnosed typhoid fever patients were bled from three different health institutions in the metropolis of Lagos, Nigeria over a period of 15 months, May 1997 to July 1998. Out of the total blood cultured, 101 (15.9%) isolates of Salmonella species were isolated of which 68 (67.3%) were S. typhi, 17 (16.8%) and 16 (15.8%) were S. paratyphi A. and S. arizonae respectively. The overall isolation rate of S. typhi among patients is 10.7%, with most isolates 45.9% found among the severely-ill young adults, age group 16-30 years. All isolates were subjected to anti-microbial susceptibility testing using 12 different antibiotics: chloramphenicol, ampicillin, cotrimoxazole, gentamicin, colistin sulfate, nalidixic acid, nitrofurantoin, cefotaxime, tetracycline, streptomycin, ofloxacin and ciprofloxacin. All the S. typhi and S. paratyphi A isolates showed resistance to two or more of the 10 of 12 antibiotics tested particularly the 3-first-line antibiotics commonly used (chloramphenicol, ampicillin and cotrimoxazole) in the treatment of typhoid fever in Nigeria. No isolate showed resistance to ofloxacin and ciprofloxacin, however, nalidixic acid and gentamicin showed a moderate and appreciable inhibition to most of our isolates.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10928566     DOI: 10.1515/znc-2000-5-630

Source DB:  PubMed          Journal:  Z Naturforsch C J Biosci        ISSN: 0341-0382


  7 in total

1.  Generation and Characterization of Typhoid Toxin-Neutralizing Human Monoclonal Antibodies.

Authors:  Xuyao Jiao; Sarah Smith; Gabrielle Stack; Qi Liang; Allan Bradley; Paul Kellam; Jorge E Galán
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

Review 2.  A Systematic Review of the Incidence, Risk Factors and Case Fatality Rates of Invasive Nontyphoidal Salmonella (iNTS) Disease in Africa (1966 to 2014).

Authors:  Ifeanyi Valentine Uche; Calman A MacLennan; Allan Saul
Journal:  PLoS Negl Trop Dis       Date:  2017-01-05

3.  Salmonellosis in Lagos, Nigeria: incidence of Plasmodium falciparum-associated co-infection, patterns of antimicrobial resistance, and emergence of reduced susceptibility to fluoroquinolones.

Authors:  Kabir O Akinyemi; Babajide S Bamiro; Akitoye O Coker
Journal:  J Health Popul Nutr       Date:  2007-09       Impact factor: 2.000

4.  Typhoid Fever: Tracking the Trend in Nigeria.

Authors:  Kabiru Olusegun Akinyemi; Akeeb Oriowo Bola Oyefolu; Wasiu Bamidele Mutiu; Bamidele Abiodun Iwalokun; Edward Sunday Ayeni; Samuel Oluwasegun Ajose; Stephen K Obaro
Journal:  Am J Trop Med Hyg       Date:  2018-07-24       Impact factor: 2.345

Review 5.  Emerging and re-emerging bacterial zoonoses in Nigeria: current preventive measures and future approaches to intervention.

Authors:  Olaitan O Omitola; Andrew W Taylor-Robinson
Journal:  Heliyon       Date:  2020-06-01

6.  Drug-resistant enteric fever worldwide, 1990 to 2018: a systematic review and meta-analysis.

Authors:  Annie J Browne; Bahar H Kashef Hamadani; Emmanuelle A P Kumaran; Puja Rao; Joshua Longbottom; Eli Harriss; Catrin E Moore; Susanna Dunachie; Buddha Basnyat; Stephen Baker; Alan D Lopez; Nicholas P J Day; Simon I Hay; Christiane Dolecek
Journal:  BMC Med       Date:  2020-01-03       Impact factor: 8.775

7.  Typhoid fever among febrile Nigerian patients: Prevalence, diagnostic performance of the Widal test and antibiotic multi-drug resistance.

Authors:  Martin E Ohanu; Michael O Iroezindu; Uzoamaka Maduakor; Obinna D Onodugo; Harish C Gugnani
Journal:  Malawi Med J       Date:  2019-09       Impact factor: 0.875

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.